Feya

𝐀 𝐟𝐢𝐯𝐞-𝐲𝐞𝐚𝐫 𝐂𝐨𝐥𝐮𝐦𝐛𝐢𝐚 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐞𝐬 𝐚 𝐫𝐚𝐩𝐢𝐝 𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐯𝐞 𝐬𝐡𝐢𝐟𝐭 𝐭𝐡𝐚𝐭 𝐝𝐢𝐦𝐢𝐧𝐢𝐬𝐡𝐞𝐬 𝐬𝐮𝐢𝐜𝐢𝐝𝐚𝐥 𝐭𝐡𝐨𝐮𝐠𝐡𝐭𝐬 𝐰𝐢𝐭𝐡 𝐨𝐧𝐥𝐲 𝐨𝐧𝐞 𝐝𝐨𝐬𝐞 𝐨𝐟 𝐤𝐞𝐭𝐚𝐦𝐢𝐧𝐞.

One of the most recent studies on ketamine (by J.G. Keilp et al., Journal of Clinical Psychiatry, 2021) indicates that one dose of ketamine not only reduced the severity of depression in people with su***de ideation, many of whom had not responded to other antidepressants, but also made them feel safer and less likely to harm themselves because it rapidly diminished their suicidal ideation.

Participants in the study who responded positively to the ketamine treatment continued to do well for up to six weeks after they were given an initial infusion.

Ketamine is clearly changing the functioning of important neurotransmitter systems in many key areas of the brain, and further study of ketamine and other drugs like it could lead to new mental health treatments, the researchers said.

Click the link in our bio to schedule a free consultation session
http://www.feyahealth.io